Dearborn Partners LLC Novartis Ag Transaction History

Dearborn Partners LLC

  • $2.05 Billion
  • Q1 2025

A detailed history of Dearborn Partners LLC transactions in Novartis Ag stock. As of the latest transaction made, Dearborn Partners LLC holds 62,173 shares of NVS stock, worth $7.39 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
62,173
Previous 62,401 0.37%
Holding current value
$7.39 Million
Previous $6.07 Million 14.15%
% of portfolio
0.34%
Previous 0.26%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 08, 2025
SELL
$97.14 - $115.57 $22,147 - $26,349
-228 Reduced 0.37%
62,173 $6.93 Million
Q4 2024

Feb 07, 2025
BUY
$96.78 - $117.18 $6,484 - $7,851
67 Added 0.11%
62,401 $6.07 Million
Q3 2024

Nov 06, 2024
BUY
$106.13 - $120.89 $2,016 - $2,296
19 Added 0.03%
62,334 $7.17 Million
Q1 2024

May 08, 2024
SELL
$95.27 - $108.47 $8,193 - $9,328
-86 Reduced 0.14%
62,315 $6.03 Million
Q4 2023

Jan 26, 2024
SELL
$92.27 - $101.54 $78,244 - $86,105
-848 Reduced 1.34%
62,401 $6.3 Million
Q3 2023

Nov 01, 2023
SELL
$94.73 - $105.13 $5,589 - $6,202
-59 Reduced 0.09%
63,249 $6.44 Million
Q2 2023

Aug 03, 2023
BUY
$92.52 - $104.91 $20,817 - $23,604
225 Added 0.36%
63,308 $6.39 Million
Q1 2023

May 04, 2023
SELL
$80.03 - $92.81 $800 - $928
-10 Reduced 0.02%
63,083 $5.8 Million
Q4 2022

Feb 02, 2023
SELL
$75.55 - $92.52 $32,410 - $39,691
-429 Reduced 0.68%
63,093 $5.72 Million
Q3 2022

Oct 25, 2022
SELL
$74.61 - $87.26 $895 - $1,047
-12 Reduced 0.02%
63,522 $4.83 Million
Q2 2022

Jul 20, 2022
SELL
$80.52 - $93.75 $2,093 - $2,437
-26 Reduced 0.04%
63,534 $5.37 Million
Q1 2022

May 04, 2022
SELL
$80.11 - $90.62 $301,774 - $341,365
-3,767 Reduced 5.6%
63,560 $5.58 Million
Q4 2021

Jan 28, 2022
SELL
$79.7 - $88.13 $1.85 Million - $2.05 Million
-23,219 Reduced 25.64%
67,327 $5.89 Million
Q3 2021

Oct 27, 2021
BUY
$81.78 - $95.14 $63,870 - $74,304
781 Added 0.87%
90,546 $7.41 Million
Q2 2021

Jul 26, 2021
BUY
$85.24 - $94.15 $84,984 - $93,867
997 Added 1.12%
89,765 $8.19 Million
Q1 2021

Apr 29, 2021
SELL
$83.5 - $98.47 $88,426 - $104,279
-1,059 Reduced 1.18%
88,768 $7.59 Million
Q4 2020

Jan 27, 2021
BUY
$78.07 - $94.43 $702,786 - $850,058
9,002 Added 11.14%
89,827 $8.48 Million
Q3 2020

Oct 20, 2020
BUY
$82.14 - $91.0 $6,242 - $6,916
76 Added 0.09%
80,825 $7.03 Million
Q2 2020

Jul 30, 2020
BUY
$80.93 - $91.1 $144,864 - $163,069
1,790 Added 2.27%
80,749 $7.05 Million
Q1 2020

May 11, 2020
BUY
$70.67 - $99.01 $107,277 - $150,297
1,518 Added 1.96%
78,959 $6.51 Million
Q4 2019

Jan 28, 2020
BUY
$84.35 - $95.37 $352,161 - $398,169
4,175 Added 5.7%
77,441 $7.33 Million
Q3 2019

Oct 29, 2019
SELL
$85.54 - $94.26 $58,081 - $64,002
-679 Reduced 0.92%
73,266 $6.37 Million
Q2 2019

Jul 29, 2019
BUY
$75.4 - $92.8 $54,061 - $66,537
717 Added 0.98%
73,945 $6.75 Million
Q1 2019

May 01, 2019
BUY
$75.32 - $86.15 $2,485 - $2,842
33 Added 0.05%
73,228 $7.04 Million
Q4 2018

Feb 04, 2019
BUY
$73.66 - $82.02 $27,769 - $30,921
377 Added 0.52%
73,195 $6.28 Million
Q3 2018

Oct 24, 2018
BUY
$66.94 - $77.43 $183,214 - $211,925
2,737 Added 3.91%
72,818 $6.27 Million
Q2 2018

Aug 14, 2018
SELL
$64.91 - $73.36 $15.3 Million - $17.2 Million
-234,998 Reduced 77.03%
70,081 $5.29 Million
Q1 2018

May 01, 2018
SELL
$70.39 - $84.15 $4.79 Million - $5.73 Million
-68,097 Reduced 18.25%
305,079 $24.7 Million
Q4 2017

Feb 02, 2018
SELL
$72.33 - $77.64 $626,522 - $672,517
-8,662 Reduced 2.27%
373,176 $31.3 Million
Q3 2017

Nov 13, 2017
SELL
$74.14 - $77.27 $638,938 - $665,912
-8,618 Reduced 2.21%
381,838 $32.8 Million
Q2 2017

Aug 09, 2017
BUY
N/A
390,456
390,456 $32.6 Million

Others Institutions Holding NVS

# of Institutions
1,523
Shares Held
142M
Call Options Held
1.63M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $256B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Dearborn Partners LLC Portfolio

Follow Dearborn Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dearborn Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dearborn Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email